Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Recent Articles in Featured Companies

Nuance Biotech Targets China and South Africa
Feb 18, 2015
Nuance Biotech, a Shanghai-based startup, has developed an unusual business model. As Mark Lotter, the company's founder and CEO, told ChinaBio® Today in an exclusive interview, Nuance plans to in-license and develop drugs in both China and South Africa. The countries are similar in many ways, explains Lotter, but South Africa's population is more diverse, which offers unique opportunities. Nuance will in-license drugs in all stages of development, from market-ready to pre-clinical. The company, which will soon begin fund raising, will attend the April ChinaBio® Partnership Forum in Shanghai to make its story better known. More details....

Share this with colleagues:  

Interview with Dr. Dan Zhang of Fountain Medical: "Get Started"
Dec 10, 2014

Dan Zhang, MD, Chairman and CEO of China CRO Fountain Medical Development, says, "Everybody thinks about China. It’s up to our clients—you—to take quick action and not wait anymore. Start from small stakes, touch the market. After all, this is going to be the world's largest pharmaceutical market, so it pays for you to do something about it." Fountain Medical is a clinical CRO that offers Phase I-IV trials in China and East Asia to its international and domestic Chinese clients. More details....

Share this with colleagues:  

Johnson & Johnson: Translation in Asia
Nov 6, 2014
Last week, Johnson & Johnson announced the opening of an Asia Pacific Innovation Center in Shanghai. The center is the company's fourth such facility around the globe, formed to increase J&J's presence in early innovation by working with partners. BioCentury talked to J&J about its program and how the Shanghai center will differ from the other three. It also found out that J&J has already signed six deals with Asia Pacific partners, four of them in China. We present the entire article here with BioCentury's gracious permission. More details...

Stock Symbol: (NYSE: JNJ)
Roche Seeks Companies with Unique Differentiators for Partners
Oct 23, 2014
In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio® Today that Roche remains entirely focused on novel drugs for unmet needs. So it's not surprising that the Swiss pharma is looking to partner with companies that have innovative drugs with unique differentiators, the potential to be either first-in-class or best-in-class. Because China's drug development scene is showing increasing levels of innovation, Dr. Ji says Roche works very hard to maintain relationships with China entrepreneurs. The company wants to bring innovative drugs to the "hugely important" China market, he adds, and it plans to bring novel China drugs to global markets.  More details....
Cellular Biomedicine's Stock Price Quadruples in Two Months
Aug 15, 2014
On Monday, August 18, Dr. William Cao, CEO of Cellular Biomedicine Group will ring the closing bell at NASDAQ to celebrate CBMG's recent listing on the exchange.  CBMG is a US-headquartered biotech that is developing new treatments for degenerative diseases and cancer in China. The NASDAQ event caps a busy two months for CBMG. During that time, the company reported positive data from a trial of its knee arthritis treatment, jettisoned its consulting business, raised $10 million in a private placement, paid $23 million to acquire a China cellular products company – and the company's stock price rose from below $6 to $23. More details....

Stock Symbol: (NSDQ: CBMG)

Share this with colleagues:  

More Articles >>
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here